Prosecution Insights
Last updated: July 17, 2026
Application No. 18/747,333

ELECTRICAL APPLICATORS WITH NON-PENETRATING ELECTRODES FOR APPLYING ENERGY TO TISSUE SURFACES

Non-Final OA §102§103
Filed
Jun 18, 2024
Priority
Dec 30, 2021 — continuation of 12/042,653
Examiner
KAHELIN, MICHAEL WILLIAM
Art Unit
3792
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Pulse Biosciences Inc.
OA Round
1 (Non-Final)
78%
Grant Probability
Favorable
1-2
OA Rounds
1y 1m
Est. Remaining
99%
With Interview

Examiner Intelligence

Grants 78% — above average
78%
Career Allowance Rate
522 granted / 671 resolved
+7.8% vs TC avg
Strong +24% interview lift
Without
With
+24.0%
Interview Lift
resolved cases with interview
Typical timeline
3y 2m
Avg Prosecution
34 currently pending
Career history
701
Total Applications
across all art units

Statute-Specific Performance

§101
1.8%
-38.2% vs TC avg
§103
69.0%
+29.0% vs TC avg
§102
8.2%
-31.8% vs TC avg
§112
9.8%
-30.2% vs TC avg
Black line = Tech Center average estimate • Based on career data from 671 resolved cases

Office Action

§102 §103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Rejections - 35 USC § 102 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. (a)(2) the claimed invention was described in a patent issued under section 151, or in an application for patent published or deemed published under section 122(b), in which the patent or application, as the case may be, names another inventor and was effectively filed before the effective filing date of the claimed invention. Claims 1, 3, 7, 8, 12, 13 and 18 are rejected under 35 U.S.C. 102(a)(1) and (2) as being anticipated by Lei (US 2015/0366747, hereinafter “Lei”). In regards to claim 1, Lei discloses an electrical applicator apparatus (abstract), the apparatus comprising: a treatment tip portion (e.g., Fig. 7, par. 0143, “treatment plug”); a first surface electrode comprising a first one or more elongate traces extending over a surface of the treatment tip portion (e.g., Figs. 7 and 15); and a second surface electrode comprising a second one or more elongate traces extending over the surface of the treatment tip portion, wherein the first one or more elongate traces extend adjacent to the second one or more traces along a length of the second one or more elongate traces so that there is a uniform gap separating the first one or more traces from the second one or more traces along the length of the second one or more traces (e.g., Figs. 7 and 15), further wherein the first surface electrode and the second surface electrode form an alternating and/or interdigitating pattern comprising an active region that spans the majority of the treatment tip portion to provide an evenly distributed electric field density over the active region (e.g., Fig. 7, par. 0055, abstract “to ensure uniform distribution between each group of RF electrode currents”). In regards to claim 3, the active region is 25 mm2 or greater (par. 0054 --2.5 cm * 7 cm * π ≈ 55 cm2. In regards to claim 7, the first one or more elongate traces are in electrical communication with a first electrical connector configured to be coupled to a pulse generator and the second one more elongate traces are in electrical communication with a second electrical connector configured to be coupled to the pulse generator (Fig. 15, positive and negative electrodes, respectively). In regards to claim 8, the first surface electrode and the second surface electrode are configured to deliver fast, high-voltage electrical pulses between the first surface electrode and the second surface electrode (pars. 0004, 0112-0115; radio frequency stimulation of a high enough voltage to heat target tissue and stimulate collagen regeneration). In regards to claim 12, Lei discloses an electrical applicator apparatus (abstract), the apparatus comprising: a treatment tip portion (e.g., Fig. 7, par. 0143, “treatment plug”); a first surface electrode and a second surface electrode configured to deliver high-voltage electrical pulses (e.g., Figs. 7 and 15; pars. 0004, 0112-0115; radio frequency stimulation of a high enough voltage to heat target tissue and stimulate collagen regeneration); wherein the first and the second surface electrodes comprising a first and a second respective patterns of one or more elongate traces extending adjacent to each other over a surface of the treatment tip portion, the first and the second patterns of the one or more elongate traces are longer than they are wide and separated by a uniform gap along a length of the respective patterns (e.g., Figs. 7 and 15), and wherein the first and the second patterns are configured to form a substantially uniform electrical field over the treatment tip portion when high-voltage electrical pulses are delivered between the first and the second electrodes (e.g., Fig. 7, par. 0055, abstract “to ensure uniform distribution between each group of RF electrode currents”). In regards to claim 13, the treatment tip portion is disposable (par. 0116, “disposable plug”). In regards to claim 18, Lei discloses a system comprising: an applicator comprising (Fig. 1, par. 0042, “applicator 3”)): a treatment tip portion (Fig. 7, par. 0042, “treatment plug”); a first surface electrode comprising a first one or more elongate traces extending over a surface of the treatment tip portion (e.g., Figs. 7 and 15); and a second surface electrode comprising a second one or more elongate traces extending over the surface of the treatment tip portion, wherein the first one or more elongate traces extend adjacent to the second one or more elongate traces along a length of the second one or more elongate traces so that there is a uniform gap separating the first one or more elongate traces from the second one or more elongate traces (e.g., Figs. 7 and 15), further wherein the first surface electrode and the second surface electrode form an alternating and/or interdigitating pattern comprising an active region that spans the majority of the treatment tip portion to provide an evenly distributed electric field density over the active region (e.g., Fig. 7, par. 0055, abstract “to ensure uniform distribution between each group of RF electrode currents”); and a pulse generator configured to generate high-voltage electric pulses, wherein the first surface electrode and the second surface electrode are configured to electrically couple to the pulse generator such that the evenly distributed electric field density is formed across the active region when the high-voltage electrical pulses are delivered between the first surface electrode and the second surface electrode (Fig. 1, “main engine 1”; abstract, “to ensure uniform distribution between each group of RF electrode currents”). Claim Rejections - 35 USC § 103 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claims 4-6 and 9 are rejected under 35 U.S.C. 103 as being unpatentable over Lei. Lei discloses the essential features of the claimed invention, including an element separating the first one or more traces from the second one or more traces (Figs. 7 and 8) and electrode dimensions and coverage that appear to overlap with the claimed ranges of gap, aspect ratio, and coverage (Fig. 7 and pars. 0055, 0129), but does not expressly disclose the gap is between 0.5 mm and 10 mm; the first one or more elongate traces have a length that is at least five times longer than a width; the active region spans at least 70% of the treatment tip portion; or that the separator comprises an insulator within the uniform gap separating the first one or more traces from the second one or more traces. However, it is well known in the art to provide the separation between therapy electrodes with an insulator to provide the predictable results of allowing a voltage to be generated between two electrodes (i.e., prevent a short circuit) to provide the predictable results of allowing energy to be delivered to tissue more efficiently, and it has been held that “"where the general conditions of a claim are disclosed in the prior art, it is not inventive to discover the optimum or workable ranges by routine experimentation." In re Aller, 220 F.2d 454, 456, 105 USPQ 233, 235 (CCPA 1955). Therefore, it would have been obvious to one having ordinary skill in the art before the effective filing date of the claimed invention to modify Lei by provide the separation between therapy electrodes with an insulator to provide the predictable results of allowing a voltage to be generated between two electrodes (i.e., prevent a short circuit) to provide the predictable results of allowing energy to be delivered to tissue more efficiently, and a gap that is between 0.5 mm and 10 mm; the first one or more elongate traces having a length that is at least five times longer than a width; and the active region spanning at least 70% of the treatment tip portion to provide no more than predictable results. Claims 2, 11 and 15 are rejected under 35 U.S.C. 103 as being unpatentable over Lei in view of Wijay et al. (US 2022/0071803, hereinafter “Wijay”). Lei discloses the essential features of the claimed invention, including providing the RF electrodes on a “flexible circuit plate” (par. 0118), but does not expressly disclose that the treatment tip portion comprises a flexible insulating substrate on which the first surface electrode and the second surface electrode extend. However, Wijay in the same field of endeavor of electrical surface applicators teaches providing a treatment tip portion that comprises a flexible insulating substrate (par. 0044, Nylon) on which the first surface electrode and the second surface electrode extend (Fig. 2, elements 250, par. 0051) to provide the predictable results of improving patient comfort (par. 0048). Therefore, it would have been obvious to one having ordinary skill in the art before the effective filing date of the claimed invention to modify Lei by providing a treatment tip portion that comprises a flexible insulating substrate on which the first surface electrode and the second surface electrode extend to provide the predictable results of improving patient comfort. Claims 10, 17 and 19 are rejected under 35 U.S.C. 103 as being unpatentable over Lei in view of Casalino et al. (US 2021/0268299, hereinafter “Casalino”). Lei discloses the essential features of the claimed invention, but does not expressly disclose wherein the first surface electrode comprises a first electrically conductive hydrogel extending to an outer, tissue-contacting surface, and wherein the second surface electrode comprises a second electrically conductive hydrogel extending to the outer, tissue-contacting surface; or wherein the pulse generator is configured to generate microsecond, nanosecond or picosecond pulses. However, Casalino in the same field of endeavor of surface electrical application teaches providing RF stimulation electrodes with hydrogel extending to an outer, tissue-contacting surface (par. 0023) to provide the predictable results of improved biocompatibility and RF energy conduction (par. 0023); and a pulse generator is configured to generate microsecond, nanosecond or picosecond pulses (par. 0018 -- the example frequencies provide pulse periods in the microsecond to nanosecond range) to provide the predictable results of more effectively cosmetically treating a patient’s skin (par. 0016). Therefore, it would have been obvious to one having ordinary skill in the art before the effective filing date of the claimed invention to modify Lei by providing RF stimulation electrodes with hydrogel extending to an outer, tissue-contacting surface to provide the predictable results of improved biocompatibility and RF energy conduction; and a pulse generator is configured to generate microsecond, nanosecond or picosecond pulses to provide the predictable results of more effectively cosmetically treating a patient’s skin. Claims 14 and 20 are rejected under 35 U.S.C. 103 as being unpatentable over Lei in view of Schwartz et al. (US 2022/0305275, hereinafter “Schwartz”). Lei discloses the essential features of the claimed invention except for one or more vacuum ports or a vacuum pump configured to provide suction to the applicator to secure the applicator to a treatment surface. However, Schwartz in the same field of endeavor of surface electrical stimulation teaches providing one or more vacuum ports and a vacuum pump configured to provide suction to the applicator to secure the applicator to a treatment surface (par. 0073) to provide the predictable results of stronger coupling of the applicator with the patient (par. 0073). Therefore, it would have been obvious to one having ordinary skill in the art before the effective filing date of the claimed invention to modify Lei by providing one or more vacuum ports and a vacuum pump configured to provide suction to the applicator to secure the applicator to a treatment surface to provide the predictable results of stronger coupling of the applicator with the patient. Claim 16 is rejected under 35 U.S.C. 103 as being unpatentable over Lei in view of Karni (US 2012/0071794, hereinafter “Karni”). Lei discloses the essential features of the claimed invention, but does not expressly disclose the apparatus is coupled to a movable arm of a robotic system. However, Karni in the same field of endeavor of RF surface application (par. 0016) teaches providing an RF apparatus coupled to a movable arm of a robotic system (abstract, Figs. 1 and 2, par. 0016) to provide the predictable results of a robotic system for delivering energy for medical or cosmetic treatment of a region of skin of a subject which would provide a simple and low cost solution to ensure correct positioning of an applicator relative to the skin surface (par. 0006). Therefore, it would have been obvious to one having ordinary skill in the art before the effective filing date of the claimed invention to modify Lei by providing the RF apparatus coupled to a movable arm of a robotic system to provide the predictable results of a robotic system for delivering energy for medical or cosmetic treatment of a region of skin of a subject which would provide a simple and low cost solution to ensure correct positioning of an applicator relative to the skin surface. Conclusion The prior art made of record and not relied upon is considered pertinent to applicant's disclosure. Prouza et al. (US 2019/0134414) is another example of an RF treatment device with a vacuum source. Any inquiry concerning this communication or earlier communications from the examiner should be directed to MICHAEL W KAHELIN whose telephone number is (571)272-8688. The examiner can normally be reached M-F, 8-5. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Benjamin Klein can be reached at (571)270-5213. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /MICHAEL W KAHELIN/Primary Examiner, Art Unit 3792
Read full office action

Prosecution Timeline

Jun 18, 2024
Application Filed
May 26, 2026
Non-Final Rejection mailed — §102, §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12678254
DRAPE MANAGEMENT SYSTEM
2y 1m to grant Granted Jul 14, 2026
Patent 12667721
BEAUTY INSTRUMENT
2y 7m to grant Granted Jun 30, 2026
Patent 12661266
SINGLE AND/OR DUAL (532 AND/OR 577) nm LASER DELIVERY SYSTEM ATTACHED TO AN OPHTHALMIC MICROSCOPE
2y 4m to grant Granted Jun 23, 2026
Patent 12642474
COMPUTATIONAL METHOD FOR LOCALIZING THE ORIGIN OF ARRHYTHMIA
2y 4m to grant Granted Jun 02, 2026
Patent 12635937
Coherence-Based Method, Apparatus, and System for Identifying Corresponding Signals of a Physiological Study
2y 5m to grant Granted May 26, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
78%
Grant Probability
99%
With Interview (+24.0%)
3y 2m (~1y 1m remaining)
Median Time to Grant
Low
PTA Risk
Based on 671 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month